dc.creator | Fuku N. | |
dc.creator | Díaz-Peña R. | |
dc.creator | Arai Y. | |
dc.creator | Abe Y. | |
dc.creator | Zempo H. | |
dc.creator | Naito H. | |
dc.creator | Murakami H. | |
dc.creator | Miyachi M. | |
dc.creator | Spuch C. | |
dc.creator | Serra-Rexach J.A. | |
dc.creator | Emanuele E. | |
dc.creator | Hirose N. | |
dc.creator | Lucia A. | |
dc.date.accessioned | 2020-09-02T22:18:04Z | |
dc.date.accessioned | 2022-11-08T20:21:34Z | |
dc.date.available | 2020-09-02T22:18:04Z | |
dc.date.available | 2022-11-08T20:21:34Z | |
dc.date.created | 2020-09-02T22:18:04Z | |
dc.date.issued | 2017 | |
dc.identifier | 18, , - | |
dc.identifier | 14712164 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4547 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144073 | |
dc.language | en | |
dc.publisher | BioMed Central Ltd. | |
dc.subject | Ageing | |
dc.subject | APOE | |
dc.subject | Centenarians | |
dc.subject | Exceptional longevity | |
dc.subject | FNDC5 | |
dc.subject | FOXO3A | |
dc.subject | apolipoprotein E | |
dc.subject | complementary RNA | |
dc.subject | cyclin dependent kinase inhibitor 2B | |
dc.subject | fibronectin | |
dc.subject | fibronectin type III domain containing 5 | |
dc.subject | glutathione peroxidase 1 | |
dc.subject | manganese superoxide dismutase | |
dc.subject | unclassified drug | |
dc.subject | apolipoprotein E | |
dc.subject | fibronectin | |
dc.subject | FNDC5 protein, human | |
dc.subject | FOXO3 protein, human | |
dc.subject | transcription factor FKHRL1 | |
dc.subject | ACTN3 gene | |
dc.subject | aged | |
dc.subject | APOE gene | |
dc.subject | Article | |
dc.subject | ASCL1 gene | |
dc.subject | CDKN2B AS1 gene | |
dc.subject | controlled study | |
dc.subject | energy metabolism | |
dc.subject | epistasis | |
dc.subject | exceptional longevity | |
dc.subject | female | |
dc.subject | FNDC5 gene | |
dc.subject | FOXOA3 gene | |
dc.subject | gene | |
dc.subject | gene frequency | |
dc.subject | gene interaction | |
dc.subject | genetic association | |
dc.subject | genetic polymorphism | |
dc.subject | genotype | |
dc.subject | GPX1 gene | |
dc.subject | human | |
dc.subject | Japanese (people) | |
dc.subject | longevity | |
dc.subject | male | |
dc.subject | physical capacity | |
dc.subject | PTK2 gene | |
dc.subject | SOD2 gene | |
dc.subject | TRHR gene | |
dc.subject | very elderly | |
dc.subject | adult | |
dc.subject | exercise | |
dc.subject | genetics | |
dc.subject | longevity | |
dc.subject | middle aged | |
dc.subject | single nucleotide polymorphism | |
dc.subject | young adult | |
dc.subject | Adult | |
dc.subject | Apolipoproteins E | |
dc.subject | Epistasis, Genetic | |
dc.subject | Exercise | |
dc.subject | Female | |
dc.subject | Fibronectins | |
dc.subject | Forkhead Box Protein O3 | |
dc.subject | Gene Frequency | |
dc.subject | Genotype | |
dc.subject | Humans | |
dc.subject | Longevity | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Polymorphism, Single Nucleotide | |
dc.subject | Young Adult | |
dc.title | Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOE | |
dc.type | Article | |